The AlphaLISA® immunoassay kit for human fatty acid binding protein 3 (FABP3) enables the quantitative determination of human FABP3 in buffer, cell cultrue media, and serum using a homogeneous AlphaLISA assay (no wash steps).
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Formats:
AlphaLISA features:
AlphaLISA technology allows the detection of molecules of interest in buffer, cell culture media, serum and plasma in a highly sensitive, quantitative, reproducible and user-friendly mode. In an AlphaLISA assay, a Biotinylated Anti-Analyte Antibody binds to the Streptavidin-coated Alpha Donor beads, while another Anti-Analyte Antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Fatty Acid-Binding Protein (FABP3) is also known as Heart-type FABP (H-FABP). FABP3 is a low molecular weight (15 kDa) protein located in the cytosol of the myocardium. During myocardial infarction, FABP3 is released into the blood where it circulates. Levels of FABP3 in the blood can be used as a marker for Acute Myocardial Infarction (AMI). Together with Troponin, FABP3 levels can be used to identify acute coronary syndrome in patients exhibiting angina.
Assay Points |
500
|
---|---|
Assay Target Class |
Protein
|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Method |
Alpha
|
Therapeutic Area |
Cardiovascular
|
Unit Size |
500 Assay Points
|
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
We are here to answer your questions.